Inari Medical 

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$153,390
$145,820
$143,194
$132,094
Gross Profit
133,544
122,278
124,301
113,955
EBITDA
-7,210
-16,608
-11,393
-947
EBIT
-12,594
-21,345
-16,009
-3,107
Net Income
-18,367
-31,348
-24,202
-4,667
Net Change In Cash
153,390
145,820
143,194
132,094
Free Cash Flow
-995
6,933
-14,198
9,841
Cash
41,141
70,192
66,707
39,208
Basic Shares
58,366
58,142
57,938
57,639

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$493,632
$383,471
$276,984
$139,670
Gross Profit
434,564
338,965
252,227
126,564
EBITDA
7,113
-18,254
15,510
16,409
EBIT
-3,632
-25,891
10,980
14,924
Net Income
-1,636
-29,267
9,840
13,789
Net Change In Cash
493,632
383,471
276,984
139,670
Cost of Revenue
-21,865
90,590
Free Cash Flow
29,726
-23,923
11,841
-3,548
Cash
38,597
60,222
92,752
114,229
Basic Shares
56,770
52,837
55,594
51,554

Earnings Calls

Quarter EPS
2024-09-30
-$0.09
2024-06-30
-$0.38
2024-03-31
-$0.22
2023-12-31
-$0.08